(19)
(11) EP 4 251 136 A1

(12)

(43) Date of publication:
04.10.2023 Bulletin 2023/40

(21) Application number: 21839690.1

(22) Date of filing: 24.11.2021
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/2086; A61K 9/2013
(86) International application number:
PCT/IT2021/050379
(87) International publication number:
WO 2022/113139 (02.06.2022 Gazette 2022/22)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 24.11.2020 IT 202000028232

(71) Applicant: Specchiasol S.r.l.
37012 Bussolengo (IT)

(72) Inventors:
  • SCIALPI, Antonio
    37026 PESCANTINA (IT)
  • GARDANA, Claudio
    24050 CIVIDATE AL PIANO (IT)
  • GIORGINI, Giuseppe
    40137 BOLOGNA (IT)

(74) Representative: Petraz, Gilberto Luigi et al
GLP S.r.l.
Viale Europa Unita, 171 33100 Udine
Viale Europa Unita, 171 33100 Udine (IT)

   


(54) FORMULATION FOR ORAL ADMINISTRATION OF ACTIVE COMPOUNDS WITH LOW BIOAVAILABILITY AND CORRESPONDING PRODUCTION METHOD